AAAAAA

   
Results: 1-7 |
Results: 7
COST OF MIGRAINE MANAGEMENT - A PHARMACOECONOMIC OVERVIEW
Authors: RAPOPORT AM ADELMAN JU
Citation: Am. Rapoport et Ju. Adelman, COST OF MIGRAINE MANAGEMENT - A PHARMACOECONOMIC OVERVIEW, American journal of managed care, 4(4), 1998, pp. 531-545
THE LONG-TERM TOLERABILITY AND EFFICACY OF ORAL ZOLMITRIPTAN (ZOMIG, 311C90) IN THE ACUTE TREATMENT OF MIGRAINE - AN INTERNATIONAL STUDY
Authors: ADELMAN JU BAUMEL B CADY RK BAKER CC COUCH JR DALESSIO DJ DIAMOND S ELKIND AH FOSTER CA GOLDSTEIN J KATZ DA KIRCHNER JR KLAPPER JA KUDROW DB KUNKEL R LANDY SH LICHT JM LINDER SL LODER E MARKLEY HG MATHEW NT MEYER JS NETT R PACKARD RC PERSE T PETERS KS RAMADAN NM RAPOPORT AM ROSING HS SADOWSKY C SAPER JR SHARFMAN MI SILBERSTEIN SD SINGER RP SMITH R SOLOMON G SOLOMON S STARK SR SWANSON JW TAYLOR FR TEPPER SJ TUCHMAN MM VIJAYAN N WALKER J WARD T WARNER JS WENDT JK WINNER P BERAN P BLACK A DONNAN G HERKES G LORD G ZAGAMI A BAUMHACKL U BROUSSALIS T KLINGLER D LADURNER G JACQUY J LOUIS P SCHOENEN J GAWEL MJ HANSEN PE JENSEN K PEDERSEN KK KORSGAARD A LADEMANN A OLESEN J SIMONSEN N SORENSEN PS JENSEN TS TFELTHANSEN P KAASIK AE ZUPPING R FARKKILA M HAANPAA M HAVANKA H HEDMAN C ILMAVIRTA M KINNUNEN E LIUKKONEN J PARTINEN M RAUTAKORPI I REUNANEN M SAKO E SEPPA JM BAREGE M CHAZOT G COLOMBANI JP DUJARDIN M FABRE N GIACOMINO A GERAUD G HENRY P",JOGEIX,"LAPORTE A",LICHTBLAU,"MASSIOU H",MAZINGUEDESAILLY,"MIHOUT B PETIT H VEYRIE M VILAREM H WILMANN JF BECKMANNREINHOLDT A DIENER HC EVERS S GOBEL H KLEPEL H KUHL W LANGOHR HD NEU I PAULUS W PEIKERT A PFAFFENRATH V SCHOLZ E STRAUBE A WITTE OW HARMOUSI S KARAGEORGIOU C MILONAS I GIACOVAZZO M NAPPI G TERBERG JWM SANDERS EACM VANDERZWAN JL EDLAND A ENGELSEN B GRONNING M HALDORSEN T HODNEBO A LARSEN JP DORNZAL T PRUSINSKI A SZCZUDLIK A NAYA MG GRANELL AN LAINEZ JM LEIRA R LIANO H PASCUAL J BOIVIE J DAHLOF C EDVINSSON L HARDEBO JE NILSSON H WALDENLIND E ISLER HR CRAWFORD P DOWSON AJ FINDLEY L GROSS M HAWKES CH JESTICO J ROLAN P STEINER TJ WILKINSON M WAGNER G
Citation: Ju. Adelman et al., THE LONG-TERM TOLERABILITY AND EFFICACY OF ORAL ZOLMITRIPTAN (ZOMIG, 311C90) IN THE ACUTE TREATMENT OF MIGRAINE - AN INTERNATIONAL STUDY, Headache, 38(3), 1998, pp. 173-183
OPTIMIZING THE DOSE OF ZOLMITRIPTAN (ZOMIG,ASTERISK 311C90) FOR THE ACUTE TREATMENT OF MIGRAINE - A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE RANGE-FINDING STUDY
Authors: RAPOPORT AM RAMADAN NM ADELMAN JU MATHEW NT ELKIND AH KUDROW DB EARL NL
Citation: Am. Rapoport et al., OPTIMIZING THE DOSE OF ZOLMITRIPTAN (ZOMIG,ASTERISK 311C90) FOR THE ACUTE TREATMENT OF MIGRAINE - A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE RANGE-FINDING STUDY, Neurology, 49(5), 1997, pp. 1210-1218
ORAL NARCOTIC PROTOCOL TO REDUCE NARCOTIC INJECTIONS IN REFRACTORY MIGRAINE PATIENTS
Authors: VONSEGGERN RL ADELMAN JU
Citation: Rl. Vonseggern et Ju. Adelman, ORAL NARCOTIC PROTOCOL TO REDUCE NARCOTIC INJECTIONS IN REFRACTORY MIGRAINE PATIENTS, Headache, 37(6), 1997, pp. 341-345
COST CONSIDERATIONS IN HEADACHE TREATMENT .2. ACUTE MIGRAINE TREATMENT
Authors: VONSEGGERN RL ADELMAN JU
Citation: Rl. Vonseggern et Ju. Adelman, COST CONSIDERATIONS IN HEADACHE TREATMENT .2. ACUTE MIGRAINE TREATMENT, Headache, 36(8), 1996, pp. 493-502
COST CONSIDERATIONS IN HEADACHE TREATMENT .1. PROPHYLACTIC MIGRAINE TREATMENT
Authors: ADELMAN JU VONSEGGERN R
Citation: Ju. Adelman et R. Vonseggern, COST CONSIDERATIONS IN HEADACHE TREATMENT .1. PROPHYLACTIC MIGRAINE TREATMENT, Headache, 35(8), 1995, pp. 479-487
POSSIBLE INCREASED RISK OF MYOCARDIAL-INFARCTION FROM CALCIUM-CHANNELBLOCKING MEDICATIONS
Authors: ADELMAN JU VONSEGGERN R
Citation: Ju. Adelman et R. Vonseggern, POSSIBLE INCREASED RISK OF MYOCARDIAL-INFARCTION FROM CALCIUM-CHANNELBLOCKING MEDICATIONS, Headache, 35(7), 1995, pp. 437-437
Risultati: 1-7 |